Literature DB >> 14597351

Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue.

Katrien De Jaeger1, Mischa S Hoogeman, Martijn Engelsman, Yvette Seppenwoolde, Eugène M F Damen, Ben J Mijnheer, Liesbeth J Boersma, Joos V Lebesque.   

Abstract

BACKGROUND AND
PURPOSE: The low density of lung tissue causes a reduced attenuation of photons and an increased range of secondary electrons, which is inaccurately predicted by the algorithms incorporated in some commonly available treatment planning systems (TPSs). This study evaluates the differences in dose in normal lung tissue computed using a simple and a more correct algorithm. We also studied the consequences of these differences on the dose-effect relations for radiation-induced lung injury.
MATERIALS AND METHODS: The treatment plans of 68 lung cancer patients initially produced in a TPS using a calculation model that incorporates the equivalent-path length (EPL) inhomogeneity-correction algorithm, were recalculated in a TPS with the convolution-superposition (CS) algorithm. The higher accuracy of the CS algorithm is well-established. Dose distributions in lung were compared using isodoses, dose-volume histograms (DVHs), the mean lung dose (MLD) and the percentage of lung receiving >20 Gy (V20). Published dose-effect relations for local perfusion changes and radiation pneumonitis were re-evaluated.
RESULTS: Evaluation of isodoses showed a consistent overestimation of the dose at the lung/tumor boundary by the EPL algorithm of about 10%. This overprediction of dose was also reflected in a consistent shift of the EPL DVHs for the lungs towards higher doses. The MLD, as determined by the EPL and CS algorithm, differed on average by 17+/-4.5% (+/-1SD). For V20, the average difference was 12+/-5.7% (+/-1SD). For both parameters, a strong correlation was found between the EPL and CS algorithms yielding a straightforward conversion procedure. Re-evaluation of the dose-effect relations showed that lung complications occur at a 12-14% lower dose. The values of the TD(50) parameter for local perfusion reduction and radiation pneumonitis changed from 60.5 and 34.1 Gy to 51.1 and 29.2 Gy, respectively.
CONCLUSIONS: A simple tissue inhomogeneity-correction algorithm like the EPL overestimates the dose to normal lung tissue. Dosimetric parameters for lung injury (e.g. MLD, V20) computed using both algorithms are strongly correlated making an easy conversion feasible. Dose-effect relations should be refitted when more accurate dose data is available.

Entities:  

Mesh:

Year:  2003        PMID: 14597351     DOI: 10.1016/s0167-8140(03)00195-6

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  23 in total

1.  An analysis of an implantable dosimeter system for external beam therapy.

Authors:  Robert D Black; Charles W Scarantino; Gregory G Mann; Mitchell S Anscher; Robert D Ornitz; Benjamin E Nelms
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

2.  Limiting the risk of cardiac toxicity with esophageal-sparing intensity modulated radiotherapy for locally advanced lung cancers.

Authors:  Katrina Woodford; Vanessa Panettieri; Jeremy D Ruben; Sashendra Senthi
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

3.  Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer.

Authors:  Takashi Uno; Koichi Isobe; Hiroyuki Kawakami; Naoyuki Ueno; Tetsuya Kawata; Seiji Yamamoto; Yasuo Sekine; Akira Iyoda; Toshihiko Iizasa; Takehiko Fujisawa; Naoyuki Shigematsu; Hisao Ito
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

4.  Dose-guided radiotherapy for lung tumors.

Authors:  Angelo Piermattei; Andrea Fidanzio; Savino Cilla; Francesca Greco; Luigi Azario; Domenico Sabatino; Mattia Grusio; Mariella Cozzolino; Vincenzo Fusco
Journal:  Med Biol Eng Comput       Date:  2009-12-10       Impact factor: 2.602

5.  Mechanistic modelling of radiotherapy-induced lung toxicity.

Authors:  E S Rutkowska; I Syndikus; C R Baker; A E Nahum
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

6.  Local control rates in stereotactic body radiotherapy (SBRT) of lung metastases associated with the biologically effective dose.

Authors:  Daniel Zucca Aparicio; Ovidio Hernando Requejo; Miguel Ángel de la Casa de Julián; Carmen Rubio Rodríguez; Pedro Fernández Letón
Journal:  Rep Pract Oncol Radiother       Date:  2019-01-22

7.  Initial clinical experience with stereotactic lung radiotherapy, based on a biological model-driven prescription method.

Authors:  C Wesley Hodge; Wolfgang A Tomé; Tracy Weigel; Anne M Traynor; Minesh P Mehta
Journal:  J Radiosurg SBRT       Date:  2011

8.  (Radio)biological optimization of external-beam radiotherapy.

Authors:  Alan E Nahum; Julien Uzan
Journal:  Comput Math Methods Med       Date:  2012-11-06       Impact factor: 2.238

9.  Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters.

Authors:  Antonella Bufacchi; Barbara Nardiello; Roberto Capparella; Luisa Begnozzi
Journal:  Radiat Oncol       Date:  2013-07-04       Impact factor: 3.481

10.  Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose.

Authors:  Danny Schuring; Coen W Hurkmans
Journal:  Radiat Oncol       Date:  2008-07-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.